Pharma’s Almanac May 2, 2023 David Alvaro Read the full article>> For years, we have known that we have an abundance of real-world data and evidence that could drive real insights and enable much more personalized medicine — in which a drug is more precisely matched to a patient rather than a more generalized population[…]
FOX News Melissa Rudy April 25, 2023 Read the full interview >> After a two-year decline, U.S. suicide rates spiked again in 2021, according to a new report from the Centers for Disease Control and Prevention (CDC). Suicide is now the 11th leading cause of death in the country — and the second among people[…]
Chief Healthcare Executive Apr 17, 2023 Ron Southwick Listen to the full podcast >> Artificial intelligence is being touted as having the potential to revolutionize healthcare. Joe Zabinski says that the future may not be too far away. “In terms of how close we are to this having widespread adoption, I think we’re closer than[…]
April 13, 2023 BusinessWire Read the full release >> The digital phenotyping platform, PhenOM, is delivering personalized and actionable healthcare insights around diagnosis, treatment, risk, utilization, and clinical trials BOSTON–(BUSINESS WIRE)–OM1, a leading real-world data, outcomes and technology company with a focus on chronic conditions, today launched PhenOM™, its artificial intelligence-powered platform for personalized medicine. Calibrated[…]
Taylor & Francis Online April 6, 2023 Read the full manuscript >> Objective: To investigate the impact of steroid-eluting implants after endoscopic sinus surgery (ESS) on health care resource use (HCRU) in chronic rhinosinusitis patients with (CRSwNP) and without (CRSsNP) nasal polyps. Methods: This retrospective, observational cohort study using real-world evidence data included adult patients[…]
